Eli Lilly is spending about $8 billion in cash to buy Loxo Oncology, as the drugmaker bulks up on cancer treatments that target certain gene abnormalities.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Eli Lilly to buy Loxo Oncology in $8 billion cancer pushThe pharmaceutical company says it is buying Loxo Oncology for $235 a share in cash, a deal that expands the company’s cancer-treatment portfolio.
Read more »
Eli Lilly to Buy Loxo Oncology in Deal It Values at About $8 BillionEli Lilly said it is buying Loxo Oncology for $235 a share—a 68% premium from Friday’s closing price—in cash, a deal that expands the biopharmaceutical company’s oncology-treatment portfolio.
Read more »
Lilly to buy Loxo Oncology in $8 billion cancer pushEli Lilly and Co said on Monday it would buy Loxo Oncology Inc for about $8 bill...
Read more »
Eli Lilly’s $8 bln cancer deal is a worthy wagerThe drug giant reckons it’ll take years to get a good return on its pricey acquisition of Loxo. But the upstart has had startling success figuring out why rare cancerous mutations occur, rather than where. Longer term, that should make for plenty of targets – and sticky prices.
Read more »
Eli Lilly CEO: Loxo acquisition can help us treat cancer globally'This is the future of cancer treatment, we believe.' Eli Lilly CEO David Ricks said that Loxo Oncology has 'harnessed the power of emerging science' and that Lilly's acquisition of Loxo can help treat cancer globally.
Read more »
Eli Lilly cuts 2019 forecast on trial failure, Loxo dealEli Lilly and Co cut its 2019 forecast for profit and revenue on Wednesday, citi...
Read more »
Pharma giant Eli Lilly just made an $8 billion bet on a cutting-edge scientific approach that uses DNA to treat cancerEli Lilly's $8 billion acquisition of biotech Loxo Oncology is a notably large deal for Eli Lilly, but it could be done again, its CEO said.
Read more »
The inside story of Eli Lilly's 18-day race to secure an $8 billion deal for a drugmaker that's pioneering a new treatment for cancerEli Lilly's $8 billion bid for Loxo Oncology was negotiated during the 2018 holiday season, so as to make a big splash at a major industry conference.
Read more »